Literature DB >> 25754818

Long noncoding RNAs: novel players in colorectal cancer.

Dong Han1, Meng Wang2, Ning Ma3, Ya Xu3, Yuting Jiang3, Xu Gao4.   

Abstract

Colorectal cancer (CRC) is the most common type of cancer in the world. Despite its commonness, the underlying mechanism of CRC is not completely understood. Long noncoding RNAs (lncRNAs) have received increased attention with the development of whole genome and transcriptome sequencing technologies. Recent findings reveal that lncRNAs are implicated in serial steps of cancer development. These lncRNAs interact with DNA, RNA, protein molecules and/or their combinations, acting as an essential regulator in chromatin organization, and transcriptional and post-transcriptional regulation. In this review, we highlight recent findings of emerging roles for lncRNAs in CRC and discuss rapid translational lncRNA research for clinical application in diagnosis, prognosis and potential treatment.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Colorectal cancer (CRC); Long noncoding RNAs; Therapeutic targets; Tumorigenesis

Mesh:

Substances:

Year:  2015        PMID: 25754818     DOI: 10.1016/j.canlet.2015.03.002

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  103 in total

1.  Long non-coding RNA bladder cancer-associated transcript 2 contributes to disease progression, chemoresistance and poor survival of patients with colorectal cancer.

Authors:  Yongjun Ren; Caixia Zhao; Yi He; Hao Xu; Xuli Min
Journal:  Oncol Lett       Date:  2019-06-18       Impact factor: 2.967

2.  LncRNA-uc.40 silence promotes P19 embryonic cells differentiation to cardiomyocyte via the PBX1 gene.

Authors:  Rongqiang Wu; Peng Xue; Yu Wan; Shizhong Wang; Meng Gu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-08-15       Impact factor: 2.416

3.  Effects of long non-coding RNA SPRY4-IT1 on osteosarcoma cell biological behavior.

Authors:  Jin Xu; Ren Ding; Yaozeng Xu
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

4.  Long non-coding RNA ZFAS1 sponges miR-484 to promote cell proliferation and invasion in colorectal cancer.

Authors:  Shuping Xie; Quanxing Ge; Xueyan Wang; Xinfang Sun; Yuhua Kang
Journal:  Cell Cycle       Date:  2018-01-17       Impact factor: 4.534

5.  Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells.

Authors:  Yuan Li; Shengkai Huang; Yan Li; Weilong Zhang; Kun He; Mei Zhao; Hong Lin; Dongdong Li; Honggang Zhang; Zhaoxu Zheng; Changzhi Huang
Journal:  Tumour Biol       Date:  2016-08-23

6.  The lncRNA XIST exhibits oncogenic properties via regulation of miR-449a and Bcl-2 in human non-small cell lung cancer.

Authors:  Ya-Long Zhang; Xue-Bing Li; Yan-Xu Hou; Nian-Zhen Fang; Jia-Cong You; Qing-Hua Zhou
Journal:  Acta Pharmacol Sin       Date:  2017-01-09       Impact factor: 6.150

Review 7.  The emerging role of noncoding RNAs in colorectal cancer chemoresistance.

Authors:  Ling Wei; Xingwu Wang; Liyan Lv; Yan Zheng; Nasha Zhang; Ming Yang
Journal:  Cell Oncol (Dordr)       Date:  2019-07-29       Impact factor: 6.730

8.  A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells.

Authors:  Gavin S Johnson; Jia Li; Laura M Beaver; W Mohaiza Dashwood; Deqiang Sun; Praveen Rajendran; David E Williams; Emily Ho; Roderick H Dashwood
Journal:  Mol Nutr Food Res       Date:  2017-01-03       Impact factor: 5.914

9.  Knockdown of HOXA-AS2 suppresses proliferation and induces apoptosis in colorectal cancer.

Authors:  Gangling Tong; Xuan Wu; Boran Cheng; Liang Li; Xi Li; Zhu Li; Qiaohong Nong; Xiaoqiu Chen; Yajie Liu; Shubin Wang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 10.  Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.

Authors:  H Wang; L Liang; J-Y Fang; J Xu
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.